Search Results - Experimental and Clinical Psychopharmacology

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents by Delia Bishara, Chris Kalafatis, David Taylor

Connect to this object online.

A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimiza... by McPherson SM, Burduli E, Smith CL, Herron J, Oluwoye O, Hirchak K, Orr MF, McDonell MG, Roll JM

Connect to this object online.

The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders by Arne Reimers, Hanna Ljung

Connect to this object online.

Cannabidiol as a potential treatment for psychosis by Cathy Davies, Sagnik Bhattacharyya

Connect to this object online.

The therapeutic potential of microdosing psychedelics in depression by Kim P.C. Kuypers

Connect to this object online.

Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update by Daniela Adamo, Elena Calabria, Noemi Coppola, Giuseppe Pecoraro, Michele Davide Mignogna

Connect to this object online.

Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study by Corrado Barbui, Federico Bertolini, Francesco Bartoli, Carmela Calandra, Camilla Callegari, Giuseppe Carrà, Armando D'Agostino, Claudio Lucii, Giovanni Martinotti, Daniele Mastromo, Daniele Moretti, Emiliano Monzani, Matteo Porcellana, Davide Prestia, Giovanni Ostuzzi

Connect to this object online.

The Potential Use of Ebselen in Treatment-Resistant Depression by Fitri Fareez Ramli, Philip J. Cowen, Beata R. Godlewska

Connect to this object online.

New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties by Yu C, Garcia-Olivares J, Candler S, Schwabe S, Maletic V

Connect to this object online.